Seeing Is Believing
Currently out of the existing stock ratings of David Arcaro, 114 are a BUY (50.89%), 48 are a HOLD (21.43%), 62 are a SELL (27.68%).
Analyst David Arcaro, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 69.34% that have a potential upside of 12.72% achieved within 184 days.
David Arcaro’s has documented 480 price targets and ratings displayed on 18 stocks. The coverage is on Utilities, Technology sectors.
Most recent stock forecast was given on CNP, CenterPoint Energy at 20-Mar-2025.
Analyst best performing recommendations are on MAXN (MAXEON SOLAR TECHNOLOGIES LTD).
The best stock recommendation documented was for MAXN (MAXEON SOLAR TECHNOLOGIES LTD) at 8/18/2022. The price target of $21 was fulfilled within 1 day with a profit of $0.85 (3.89%) receiving and performance score of 38.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$120
$10.16 (9.25%)
$116
5 days ago
(09-Apr-2025)
4/6 (66.67%)
$14.23 (13.45%)
447
Sell
$91
$-18.84 (-17.15%)
$84
25 days ago
(20-Mar-2025)
12/32 (37.5%)
$-17.48 (-16.11%)
87
Hold
$101
$-8.84 (-8.05%)
$100
1 months 21 days ago
(24-Feb-2025)
5/7 (71.43%)
$2.74 (2.79%)
71
Sell
$95
$-14.84 (-13.51%)
$92
1 months 21 days ago
(24-Feb-2025)
15/18 (83.33%)
$-3.26 (-3.32%)
129
Hold
$95
$-14.84 (-13.51%)
$106
2 months 11 days ago
(03-Feb-2025)
29/29 (100%)
$-0.62 (-0.65%)
609
Which stock is David Arcaro is most bullish on?
Which stock is David Arcaro is most reserved on?
What Year was the first public recommendation made by David Arcaro?